Secular trends in outcomes for fanconi anemia patients who receive transplants: Implications for future studies

Biology of Blood and Marrow Transplantation

Volumn 11, Issue 9, 2005, Pages 672-679

  Rosenberg, Philip S ^a   Alter, Blanche P ^a   Socié, Gerard ^b   Gluckman, Eliane ^b  

^a NATIONAL CANCER INSTITUTE   (United States)

^b SAINT LOUIS HOSPITAL   (France)

Author keywords

Fanconi anemia; Numerical data; Risk assessment; Statistics; Stem cell transplant; Study design

Indexed keywords

ALEMTUZUMAB; BUSULFAN; CYCLOPHOSPHAMIDE; FLUDARABINE; THYMOCYTE ANTIBODY;

ACUTE GRAFT VERSUS HOST DISEASE; ARTICLE; CASE STUDY; CLINICAL PROTOCOL; COHORT ANALYSIS; CONFIDENCE INTERVAL; CONTROLLED STUDY; FANCONI ANEMIA; FOLLOW UP; FRANCE; GRAFT SURVIVAL; HEALTH CARE FACILITY; HIGH RISK PATIENT; HUMAN; LIVING DONOR; LONGITUDINAL STUDY; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MORTALITY; SAMPLE SIZE; SIBLING; STATISTICAL ANALYSIS; TREATMENT OUTCOME; WHOLE BODY RADIATION;

BONE MARROW TRANSPLANTATION; FANCONI ANEMIA; FEMALE; GRAFT VS HOST DISEASE; HISTOCOMPATIBILITY TESTING; HUMANS; LIVING DONORS; MALE; MULTICENTER STUDIES; NEOPLASMS, SQUAMOUS CELL; RETROSPECTIVE STUDIES; RISK FACTORS; TRANSPLANTS;

EID: 23944433097     PISSN: 10838791     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbmt.2005.05.007     Document Type: Article

References (20)

1. D'Andrea AD, Grompe M. The Fanconi anaemia/BRCA pathway. Nat Rev Cancer. 2003;3:23-34
2. Alter BP. Inherited bone marrow failure syndromes. In: Nathan DG, Orkin SH, Look AT, Ginsburg D, eds. Hematology of Infancy and Childhood. Philadelphia: WB Saunders Inc.; 2003:280-365
3. Rosenberg PS, Greene MH, Alter BP. Cancer incidence in persons with Fanconi anemia. Blood. 2003;101:822-826
4. Gluckman E. Allogeneic bone marrow transplantation in Fanconi anemia. Bone Marrow Transplant. 1996;18(suppl 2):140-144
5. Rosenberg PS, Socie G, Alter BP, et al. Risk of head and neck squamous cell cancer and death in patients with Fanconi anemia who did and did not receive transplants. Blood. 2005;105:67-73
6. Deeg HJ, Socie G, Schoch G, et al. Malignancies after marrow transplantation for aplastic anemia and Fanconi anemia: A joint Seattle and Paris analysis of results in 700 patients. Blood. 1996;87:386-392
7. Guardiola P, Socie G, Li X, et al. Acute graft-versus-host disease in patients with Fanconi anemia or acquired aplastic anemia undergoing bone marrow transplantation from HLAidentical sibling donors: Risk factors and influence on outcome. Blood. 2004;103:73-77
8. Boulad F, Gillio A, Small TN, et al. Stem cell transplantation for the treatment of Fanconi anaemia using a fludarabine-based cytoreductive regimen and T-cell-depleted related HLA-mismatched peripheral blood stem cell grafts. Br J Haematol. 2000; 111:1153-1157
9. Boyer MW, Gross TG, Loechelt B, et al. Low risk of graftversus-host disease with transplantation of CD34 selected peripheral blood progenitor cells from alternative donors for Fanconi anemia. J Pediatr Hematol Oncol. 2003;25:890-895
10. Kapelushnik J, Or R, Slavin S, et al. A fludarabine-based protocol for bone marrow transplantation in Fanconi's anemia. Bone Marrow Transplant. 1997;20:1109-1110
11. de Medeiros CR, Zanis-Neto J, Pasquini R. Bone marrow transplantation for patients with Fanconi anemia: Reduced doses of cyclophosphamide without irradiation as conditioning. Bone Marrow Transplant. 1999;24:849-852
12. de Medeiros CR, Silva LM, Pasquini R. Unrelated cord blood transplantation in a Fanconi anemia patient using fludarabinebased conditioning. Bone Marrow Transplant. 2001;28:110-112
13. Gehan EA, Freireich EJ. Non-randomized controls in cancer clinical trials. N Engl J Med. 1974;290:198-203
14. Guardiola P, Pasquini R, Dokal I, et al. Outcome of 69 allogeneic stem cell transplantations for Fanconi anemia using HLA-matched unrelated donors: A study on behalf of the European Group for Blood and Marrow Transplantation. Blood. 2000;95:422-429
15. Rosner B. Fundamentals of Biostatistics. 4th ed. Belmont, CA: Duxbury Press; 1995
16. Dufour C, Rondelli R, Locatelli F, et al. Stem cell transplantation from HLA-matched related donor for Fanconi's anaemia: A retrospective review of the multicentric Italian experience on behalf of AIEOP-GITMO. Br J Haematol. 2001;112:796-805
17. Ayas M, Solh H, Mustafa MM, et al. Bone marrow transplantation from matched siblings in patients with Fanconi anemia utilizing low-dose cyclophosphamide, thoracoabdominal radiation and antithymocyte globulin. Bone Marrow Transplant. 2001;27:139-143
18. MacMillan ML, Auerbach AD, Davies SM, et al. Haematopoietic cell transplantation in patients with Fanconi anaemia using alternate donors: results of a total body irradiation dose escalation trial. Br J Haematol. 2000;109:121-129
19. Ayas M, Al-Jefri A, Al-Mahr M, et al. Stem cell transplantation for patients with Fanconi anemia with low-dose cyclophosphamide and antithymocyte globulins without the use of radiation therapy. Bone Marrow Transplant. 2005;35:463-466
20. Gehan EA. The evaluation of therapies: Historical control studies. Stat Med. 1984;3:315-324